GlobeNewswire Inc | Jan 6, 2021 08:00AM EST

January 06, 2021

SAN DIEGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function, today announced that it will present at theH.C. Wainwright BIOCONNECT 2021 Virtual Conference.

Presentation DetailsThe presentation will be available for on-demand listening beginning Monday, January 11, 2021, at 6:00 a.m. Eastern Time on the Investors section of the Histogen website at www.histogen.com, under the New and Events tab.

Webcast Link: https://journey.ct.events/view/dccb42bf-3f14-42b9-a4b2-09c945ccd06c

About HistogenHistogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function. Histogens innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogens proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visitwww.histogen.com.

Contact: Susan A. Knudson Executive Vice President & CFO Histogen Inc. ir@histogen.com